These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35173167)

  • 1. The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system.
    Ji CH; Kim HY; Lee MJ; Heo AJ; Park DY; Lim S; Shin S; Ganipisetti S; Yang WS; Jung CA; Kim KY; Jeong EH; Park SH; Bin Kim S; Lee SJ; Na JE; Kang JI; Chi HM; Kim HT; Kim YK; Kim BY; Kwon YT
    Nat Commun; 2022 Feb; 13(1):904. PubMed ID: 35173167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera).
    Ji CH; Lee MJ; Kim HY; Heo AJ; Park DY; Kim YK; Kim BY; Kwon YT
    Autophagy; 2022 Sep; 18(9):2259-2262. PubMed ID: 35722947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology.
    Lee J; Sung KW; Bae EJ; Yoon D; Kim D; Lee JS; Park DH; Park DY; Mun SR; Kwon SC; Kim HY; Min JO; Lee SJ; Suh YH; Kwon YT
    Mol Neurodegener; 2023 Jun; 18(1):41. PubMed ID: 37355598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted degradation of SNCA/α-synuclein aggregates in neurodegeneration using the AUTOTAC chemical platform.
    Lee J; Yoon D; Sung KW; Bae EJ; Park DH; Suh YH; Kwon YT
    Autophagy; 2024 Feb; 20(2):463-465. PubMed ID: 37915239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to detect AUTOphagy-Targeting Chimera (AUTOTAC)-mediated Targeted Protein Degradation in Tauopathies.
    Lee MJ; Kim SB; Kim HY; Lee SJ; Lee JS; Kwon YT; Ji CH
    Bio Protoc; 2023 Jan; 13(2):e4594. PubMed ID: 36789169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of autophagic proteolysis by the N-recognin SQSTM1/p62 of the N-end rule pathway.
    Cha-Molstad H; Lee SH; Kim JG; Sung KW; Hwang J; Shim SM; Ganipisetti S; McGuire T; Mook-Jung I; Ciechanover A; Xie XQ; Kim BY; Kwon YT
    Autophagy; 2018; 14(2):359-361. PubMed ID: 29261001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Protein Degradation via Lysosomes.
    Paudel RR; Lu D; Roy Chowdhury S; Monroy EY; Wang J
    Biochemistry; 2023 Feb; 62(3):564-579. PubMed ID: 36130224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the undruggables-the power of protein degraders.
    Zhang C; Liu Y; Li G; Yang Z; Han C; Sun X; Sheng C; Ding K; Rao Y
    Sci Bull (Beijing); 2024 Jun; 69(11):1776-1797. PubMed ID: 38614856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubr1-induced selective endophagy/autophagy protects against the endosomal and Ca
    Wang BB; Xu H; Isenmann S; Huang C; Elorza-Vidal X; Rychkov GY; Estévez R; Schittenhelm RB; Lukacs GL; Apaja PM
    Cell Mol Life Sci; 2022 Mar; 79(3):167. PubMed ID: 35233680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy mediated targeting degradation, a promising strategy in drug development.
    Zhang J; Pan X; Ji W; Zhou J
    Bioorg Chem; 2024 Aug; 149():107466. PubMed ID: 38843684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protein induced proximity and targeted degradations by new degraders: concepts, developments, challenges for clinical applications].
    Reboud-Ravaux M
    Biol Aujourdhui; 2024; 218(1-2):41-54. PubMed ID: 39007776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
    Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
    Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis.
    Cha-Molstad H; Yu JE; Feng Z; Lee SH; Kim JG; Yang P; Han B; Sung KW; Yoo YD; Hwang J; McGuire T; Shim SM; Song HD; Ganipisetti S; Wang N; Jang JM; Lee MJ; Kim SJ; Lee KH; Hong JT; Ciechanover A; Mook-Jung I; Kim KP; Xie XQ; Kwon YT; Kim BY
    Nat Commun; 2017 Jul; 8(1):102. PubMed ID: 28740232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/α-1-antitrypsin Z variant via SQSTM1/p62-dependent selective autophagy.
    Feng L; Zhang J; Zhu N; Ding Q; Zhang X; Yu J; Qiang W; Zhang Z; Ma Y; Huang D; Shen Y; Fang S; Yu Y; Wang H; Shen Y
    Autophagy; 2017 Apr; 13(4):686-702. PubMed ID: 28121484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective degradation of EGFR
    Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
    Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle.
    Fuqua JD; Mere CP; Kronemberger A; Blomme J; Bae D; Turner KD; Harris MP; Scudese E; Edwards M; Ebert SM; de Sousa LGO; Bodine SC; Yang L; Adams CM; Lira VA
    FASEB J; 2019 Nov; 33(11):11735-11745. PubMed ID: 31361156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into degradation mechanism of N-end rule substrates by p62/SQSTM1 autophagy adapter.
    Kwon DH; Park OH; Kim L; Jung YO; Park Y; Jeong H; Hyun J; Kim YK; Song HK
    Nat Commun; 2018 Aug; 9(1):3291. PubMed ID: 30120248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagic Pathways to Clear the Tau Aggregates in Alzheimer's Disease.
    Gorantla NV; Chinnathambi S
    Cell Mol Neurobiol; 2021 Aug; 41(6):1175-1181. PubMed ID: 32529542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Lysosome Targeting Chimera for Targeted Protein Degradation via Split-and-Mix Strategy.
    Wang J; Wang Y; Yang F; Luo Q; Hou Z; Xing Y; Lu F; Li Z; Yin F
    ACS Chem Biol; 2024 May; 19(5):1161-1168. PubMed ID: 38662199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.
    Zheng ZG; Zhu ST; Cheng HM; Zhang X; Cheng G; Thu PM; Wang SP; Li HJ; Ding M; Qiang L; Chen XW; Zhong Q; Li P; Xu X
    Autophagy; 2021 Jul; 17(7):1592-1613. PubMed ID: 32432943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.